The molecular mechanisms of vulpinic acid induced programmed cell death in melanoma

Mol Biol Rep. 2022 Sep;49(9):8273-8280. doi: 10.1007/s11033-022-07619-3. Epub 2022 Aug 12.

Abstract

Backgrounds: Malignant melanoma is an aggressive skin tumor with a rapidly increasing incidence and there is not yet a successful treatment strategy. Vulpinic acid (VA) is derived from secondary metabolites from lichen species. In the current study, we, for the first time, investigated the anti-cancer effects of VA and the underlying mechanism VA induced programmed cell death in melanoma.

Methods: The anti-cancer effects of VA on melanoma cells were evaluated by the xCELLigence system, flow cytometry, caspase-3 activity and RT-PCR analysis.

Results: Our results showed that VA had a strong anti-proliferative effect on A-375 melanoma cells without damaging human epidermal melanocyte cells. Additionally, VA promoted apoptotic cell death through G2/M arrest and the activation of both intrinsic and extrinsic apoptosis pathways according to the analysis of 88 genes associated with apoptosis by qRT-PCR.

Conclusions: Our findings suggest that VA could become an alternative topical and transdermal treatment strategy in the treatment of maligned melanoma cancer. However, further investigations are needed to assess the underlying molecular mechanism of VA mediated apoptotic cell death in the treatment of melanoma.

Keywords: Apoptosis; Melanoma; Vulpinic acid.

MeSH terms

  • Apoptosis*
  • Cell Line, Tumor
  • Furans
  • G2 Phase Cell Cycle Checkpoints
  • Humans
  • Melanoma* / drug therapy
  • Melanoma* / genetics
  • Melanoma* / metabolism
  • Phenylacetates

Substances

  • Furans
  • Phenylacetates
  • vulpinic acid